AlphaQuest’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,313
Closed -$219K 2159
2025
Q4
$219K Sell
8,313
-158
-2% -$3.45K 0.01% 1397
2025
Q3
$145K Sell
8,471
-5,555
-40% -$79.5K 0.01% 1566
2025
Q2
$176K Sell
14,026
-17,650
-56% -$210K 0.02% 1204
2025
Q1
$377K Buy
31,676
+28,868
+1,028% +$394K 0.04% 661
2024
Q4
$41.1K Buy
2,808
+2,324
+480% +$32.5K 0.01% 1326
2024
Q3
$6.07K Sell
484
-8,725
-95% -$95K ﹤0.01% 1574
2024
Q2
$78.4K Buy
9,209
+9,096
+8,050% +$81K 0.01% 994
2024
Q1
$1.19K Buy
+113
New +$1.25K ﹤0.01% 1312

Other funds holding ZYME

AlphaQuest's ZYME Position: Q1 2026 in Review

AlphaQuest sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 8,313 shares — an estimated $219K sold.

AlphaQuest first reported a position in ZYME in Q1 2024 and held it in 8 quarters. The position peaked at $377K in Q1 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • AlphaQuest reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 8,313 Zymeworks shares in Q1 2026, an estimated $219K.
  • AlphaQuest first reported a position in Zymeworks in Q1 2024 and held it in 8 quarters.
  • AlphaQuest's Zymeworks position peaked at $377K in Q1 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.